Joyzyme Group Limited (HKG:8622)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.335
+0.010 (3.08%)
Apr 29, 2026, 3:09 PM HKT
-6.94%
Market Cap 172.68M
Revenue (ttm) 31.47M
Net Income (ttm) -5.57M
Shares Out 515.47M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 160,000
Average Volume 307,200
Open 0.330
Previous Close 0.325
Day's Range 0.330 - 0.340
52-Week Range 0.285 - 0.750
Beta 0.75
RSI 52.55
Earnings Date Aug 7, 2026

About Joyzyme Group

Joyzyme Group Limited, an investment holding company, engages in the research, production, and sale of male fertility in-vitro diagnostic (IVD) reagents in the People's Republic of China. The company provides biological reagents, including male fertility IVD reagents, parasite antibody detection reagents, and Epstein-Barr virus antibody detection reagent; and auxiliary reproductive supplies and equipment. The company sells its products directly to hospitals and medical institutions, as well as to distributors. The company was formerly known as ... [Read more]

Sector Healthcare
Founded 1992
Employees 101
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 8622
Full Company Profile

Financial Performance

In 2025, Joyzyme Group's revenue was 28.28 million, an increase of 11.53% compared to the previous year's 25.36 million. Losses were -5.01 million, 20.4% more than in 2024.

Financial numbers in CNY Financial Statements

News

There is no news available yet.